Study about factors influencing alfa1-microglobulin removal ratio in patients on online hemodiafiltration

Cross-sectional study about factors influencing alfa1-microglobulin removal ratio in patients on predilution online hemodiafiltration - Cross-sectional study about factors influencing alfa1-microglobulin removal ratio in pre-OHDF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055718

Enrollment

100

Registered

2025-03-31

Start date

2024-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with end-stage kidney disease undergoing predilution online hemodiafiltration

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent predilution online hemodialysis using a dialysis machine (TPM 3-point method) as of July 1, 2023

Exclusion criteria

Exclusion criteria: 1 Missing data for covariates at study entry 2 Implemented less than 3 months ago as of July 1, 2023 3 Blood purification methods other than OHDF 4 Dialysis frequency below 3 sessions per week or dialysis time below 3 hour per session 5 Substitution volume less than 60L 6 Alfa1-microglobulin removal ratio is negative

Design outcomes

Primary

Measure	Time frame
Significant factors associated with alfa1-MG removal ratio (univariate analysis and multivariate analysis)	—

Countries

Japan

Contacts

Public ContactManabu Tashiro

Social medical corporation Kawashimakai Kawashima Hospital Department of Nephrology

m.tashiro@khg.or.jp088-631-0110

Outcome results